SCHEMBL20103318

SCHEMBL20103318

C=C(C)CCc1cccc(CCC2CCC(c3cc(CC)ccc3F)CC2)c1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.35
MAOA P21397 1/20 0.35
OPRL1 P41146 14/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20103408 0.85 OPRL1 (0.32) MAOBMAOAOPRL1
SCHEMBL20103475 0.76 FFAR1 (0.43)
SCHEMBL18295013 0.74 SOS1 (0.40) OPRL1
SCHEMBL20103295 0.74 FFAR1 (0.48)
SCHEMBL20103372 0.74 ESR1 (0.39) OPRL1
SCHEMBL21644870 0.74 ESR1 (0.39) OPRL1
SCHEMBL20103549 0.73 FFAR1 (0.52)
SCHEMBL20103371 0.71 LNPEP (0.35)
SCHEMBL14297935 0.69 BACE1 (0.44) OPRL1
SCHEMBL765783 0.69 BACE1 (0.41) OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081047-A1 CYCLOHEXYL GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES JANSSEN PHARMACEUTICA NV (BE) 2018-05-03 WO disclosed